In vivo and in vitro efficacy of minocycline-based combination therapy for minocycline-resistant Acinetobacter baumannii

Antimicrobial Agents and Chemotherapy

Volumn 60, Issue 7, 2016, Pages 4047-4054

  Yang, Ya Sung ^a   Lee, Yi ^a,b   Tseng, Kuo Chuan ^c   Huang, Wei Cheng ^c   Chuang, Ming Fen ^d,e   Kuo, Shu Chen ^c,d   Lauderdale, Tsai Ling Yang ^c   Chen, Te Li ^b,e  

^a TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^b NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^c NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^d TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^e NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CEFEPIME; CEFOPERAZONE; CEFOPERAZONE PLUS SULBACTAM; CEFTAZIDIME; CIPROFLOXACIN; COLISTIN; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; MEROPENEM; MINOCYCLINE; PIPERACILLIN PLUS TAZOBACTAM; SULBACTAM; SULTAMICILLIN; ANTIINFECTIVE AGENT; CEPHALOSPORIN DERIVATIVE; PENICILLANIC ACID; PIPERACILLIN; PIPERACILLIN, TAZOBACTAM DRUG COMBINATION; THIENAMYCIN DERIVATIVE;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; ANIMAL EXPERIMENT; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL LOAD; BACTERIAL SURVIVAL; BACTERIUM ISOLATE; BIOFILM; COLONY FORMING UNIT; COMBINATION DRUG THERAPY; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENTIATION; FRACTIONAL INHIBITORY CONCENTRATION INDEX; HEALTH CARE; IN VITRO STUDY; IN VIVO STUDY; LOW DRUG DOSE; LUNG; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TAIWAN; ACINETOBACTER INFECTIONS; ANALOGS AND DERIVATIVES; ANIMAL; DRUG EFFECTS; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MULTIDRUG RESISTANCE; PNEUMONIA;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ANIMALS; ANTI-BACTERIAL AGENTS; BIOFILMS; CEPHALOSPORINS; COLISTIN; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GENTAMICINS; IMIPENEM; MICE; MICROBIAL SENSITIVITY TESTS; MINOCYCLINE; PENICILLANIC ACID; PIPERACILLIN; PNEUMONIA; TAIWAN; THIENAMYCINS;

EID: 84977126028     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.02994-15     Document Type: Article

References (32)

1. Taneja N, Singh G, Singh M, Sharma M. 2011. Emergence of tigecycline & colistin resistant Acinetobacter baumanii in patients with complicated urinary tract infections in north India. Indian J Med Res 133:681-684.
2. Ritchie DJ, Garavaglia-Wilson A. 2014. A review of intravenous minocycline for treatment of multidrug-resistant Acinetobacter infections. Clin Infect Dis 59(Suppl 6):S374-S380. http://dx.doi.org/10.1093/cid/ciu613.
3. Goff DA, Bauer KA, Mangino JE. 2014. Bad bugs need old drugs: a stewardship program's evaluation of minocycline for multidrug-resistant Acinetobacter baumannii infections. Clin Infect Dis 59(Suppl 6):S381-S387. http://dx.doi.org/10.1093/cid/ciu593.
4. Castanheira M, Mendes RE, Jones RN. 2014. Update on Acinetobacter species: mechanisms of antimicrobial resistance and contemporary in vitro activity of minocycline and other treatment options. Clin Infect Dis 59(Suppl 6):S367-S373. http://dx.doi.org/10.1093/cid/ciu706.
5. Agwuh KN, MacGowan A. 2006. Pharmacokinetics and pharmacodynamics of the tetracyclines including glycylcyclines. J Antimicrob Chemother 58:256-265. http://dx.doi.org/10.1093/jac/dkl224.
6. Brogden RN, Speight TM, Avery GS. 1975. Minocycline: a review of its antibacterial and pharmacokinetic properties and therapeutic use. Drugs 9:251-291. http://dx.doi.org/10.2165/00003495-197509040-00005.
7. Kuo SC, Chang SC, Wang HY, Lai JF, Chen PC, Shiau YR, Huang IW, Lauderdale TL, TSAR Hospitals. 2012. Emergence of extensively drug-resistant Acinetobacter baumannii complex over 10 years: nationwide data from the Taiwan Surveillance of Antimicrobial Resistance (TSAR) program. BMC Infect Dis 12:200. http://dx.doi.org/10.1186/1471-2334-12-200.
8. Coyne S, Courvalin P, Perichon B. 2011. Efflux-mediated antibiotic resistance in Acinetobacter spp. Antimicrob Agents Chemother 55:947-953. http://dx.doi.org/10.1128/AAC.01388-10.
9. Vilacoba E, Almuzara M, Gulone L, Traglia GM, Figueroa SA, Sly G, Fernandez A, Centron D, Ramirez MS. 2013. Emergence and spread of plasmid-borne tet(B)::ISCR2 in minocycline-resistant Acinetobacter baumannii isolates. Antimicrob Agents Chemother 57:651-654. http://dx.doi.org/10.1128/AAC.01751-12.
10. Zusman O, Avni T, Leibovici L, Adler A, Friberg L, Stergiopoulou T, Carmeli Y, Paul M. 2013. Systematic review and meta-analysis of in vitro synergy of polymyxins and carbapenems. Antimicrob Agents Chemother 57:5104-5111. http://dx.doi.org/10.1128/AAC.01230-13.
11. Chen TL, Siu LK, Wu RC, Shaio MF, Huang LY, Fung CP, Lee CM, Cho WL. 2007. Comparison of one-tube multiplex PCR, automated ribotyping and intergenic spacer (ITS) sequencing for rapid identification of Acinetobacter baumannii. Clin Microbiol Infect 13:801-806. http://dx.doi.org/10.1111/j.1469-0691.2007.01744.x.
12. Huang LY, Chen TL, Lu PL, Tsai CA, Cho WL, Chang FY, Fung CP, Siu LK. 2008. Dissemination of multidrug-resistant, class 1 integron-carrying Acinetobacter baumannii isolates in Taiwan. Clin Microbiol Infect 14:1010-1019. http://dx.doi.org/10.1111/j.1469-0691.2008.02077.x.
13. Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, Swaminathan B. 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 33:2233-2239.
14. Hornsey M, Longshaw C, Phee L, Wareham DW. 2012. In vitro activity of telavancin in combination with colistin versus Gram-negative bacterial pathogens. Antimicrob Agents Chemother 56:3080-3085. http://dx.doi.org/10.1128/AAC.05870-11.
15. Petersen PJ, Labthavikul P, Jones CH, Bradford PA. 2006. In vitro antibacterial activities of tigecycline in combination with other antimicrobial agents determined by chequerboard and time-kill kinetic analysis. J Antimicrob Chemother 57:573-576. http://dx.doi.org/10.1093/jac/dki477.
16. Hengzhuang W, Ciofu O, Yang L, Wu H, Song Z, Oliver A, Hoiby N. 2013. High beta-lactamase levels change the pharmacodynamics of beta-lactam antibiotics in Pseudomonas aeruginosa biofilms. Antimicrob Agents Chemother 57:196-204. http://dx.doi.org/10.1128/AAC.01393-12.
17. Bowers DR, Cao H, Zhou J, Ledesma KR, Sun D, Lomovskaya O, Tam VH. 2015. Assessment of minocycline and polymyxin B combination against Acinetobacter baumannii. Antimicrob Agents Chemother 59:2720-2725. http://dx.doi.org/10.1128/AAC.04110-14.
18. Fitzpatrick MA, Ozer EA, Hauser AR. 2016. Utility of whole-genome sequencing in characterizing Acinetobacter epidemiology and analyzing hospital outbreaks. J Clin Microbiol 54:593-612. http://dx.doi.org/10.1128/JCM.01818-15.
19. Reuter S, Ellington MJ, Cartwright EJ, Koser CU, Torok ME, Gouliouris T, Harris SR, Brown NM, Holden MT, Quail M, Parkhill J, Smith GP, Bentley SD, Peacock SJ. 2013. Rapid bacterial whole-genome sequencing to enhance diagnostic and public health microbiology. JAMA Intern Med 173:1397-1404. http://dx.doi.org/10.1001/jamainternmed.2013.7734.
20. Wright MS, Haft DH, Harkins DM, Perez F, Hujer KM, Bajaksouzian S, Benard MF, Jacobs MR, Bonomo RA, Adams MD. 2014. New insights into dissemination and variation of the health care-associated pathogen Acinetobacter baumannii from genomic analysis. mBio 5:e00963-13. http://dx.doi.org/10.1128/mBio.00963-13.
21. Rumbo C, Gato E, Lopez M, Ruiz de Alegria C, Fernandez-Cuenca F, Martinez-Martinez L, Vila J, Pachon J, Cisneros JM, Rodriguez-Bano J, Pascual A, Bou G, Tomas M, Spanish Group of Nosocomial Infections and Mechanisms of Action and Resistance to Antimicrobials (GEIH-GEMARA), Spanish Society of Clinical Microbiology and Infectious Diseases (SEIMC), Spanish Network for Research in Infectious Diseases (REIPI). 2013. Contribution of efflux pumps, porins, and β-lactamases to multidrug resistance in clinical isolates of Acinetobacter baumannii. Antimicrob Agents Chemother 57:5247-5257. http://dx.doi.org/10.1128/AAC.00730-13.
22. Liang W, Liu XF, Huang J, Zhu DM, Li J, Zhang J. 2011. Activities of colistin- and minocycline-based combinations against extensive drug resistant Acinetobacter baumannii isolates from intensive care unit patients. BMC Infect Dis 11:109. http://dx.doi.org/10.1186/1471-2334-11-109.
23. Tan TY, Ng LS, Tan E, Huang G. 2007. In vitro effect of minocycline and colistin combinations on imipenem-resistant Acinetobacter baumannii clinical isolates. J Antimicrob Chemother 60:421-423. http://dx.doi.org/10.1093/jac/dkm178.
24. Gordon NC, Png K, Wareham DW. 2010. Potent synergy and sustained bactericidal activity of a vancomycin-colistin combination versus multidrug-resistant strains of Acinetobacter baumannii. Antimicrob Agents Chemother 54:5316-5322. http://dx.doi.org/10.1128/AAC.00922-10.
25. Sheng WH, Wang JT, Li SY, Lin YC, Cheng A, Chen YC, Chang SC. 2011. Comparative in vitro antimicrobial susceptibilities and synergistic activities of antimicrobial combinations against carbapenem-resistant Acinetobacter species: Acinetobacter baumannii versus Acinetobacter genospecies 3 and 13TU. Diagn Microbiol Infect Dis 70:380-386. http://dx.doi.org/10.1016/j.diagmicrobio.2011.03.003.
26. March GA, Bratos MA. 2015. A meta-analysis of in vitro antibiotic synergy against Acinetobacter baumannii. J Microbiol Methods 119:31-36. http://dx.doi.org/10.1016/j.mimet.2015.09.014.
27. Lora-Tamayo J, Murillo O, Bergen PJ, Nation RL, Poudyal A, Luo XL, Yu HY, Ariza J, Li J. 2014. Activity of colistin combined with doripenem at clinically relevant concentrations against multidrug-resistant Pseudomonas aeruginosa in an in vitro dynamic biofilm model. J Antimicrob Chemother 69:2434-2442. http://dx.doi.org/10.1093/jac/dku151.
28. Ni W, Shao X, Di X, Cui J, Wang R, Liu Y. 2015. In vitro synergy of polymyxins with other antibiotics for Acinetobacter baumannii: a systematic review and meta-analysis. Int J Antimicrob Agents 45:8-18. http://dx.doi.org/10.1016/j.ijantimicag.2014.10.002.
29. Rodriguez CH, Nastro M, Vay C, Famiglietti A. 2015. In vitro activity of minocycline alone or in combination in multidrug-resistant Acinetobacter baumannii isolates. J Med Microbiol 64:1196-1200. http://dx.doi.org/10.1099/jmm.0.000147.
30. Gaddy JA, Actis LA. 2009. Regulation of Acinetobacter baumannii biofilm formation. Future Microbiol 4:273-278. http://dx.doi.org/10.2217/fmb.09.5.
31. Jamal MA, Rosenblatt JS, Hachem RY, Ying J, Pravinkumar E, Nates JL, Chaftari AM, Raad II. 2014. Prevention of biofilm colonization by Gram-negative bacteria on minocycline-rifampin-impregnated catheters sequentially coated with chlorhexidine. Antimicrob Agents Chemother 58:1179-1182. http://dx.doi.org/10.1128/AAC.01959-13.
32. Ozbek B, Mataraci E. 2013. In vitro effectiveness of colistin, tigecycline and levofloxacin alone and combined with clarithromycin and/or heparin as lock solutions against embedded Acinetobacter baumannii strains. J Antimicrob Chemother 68:827-830. http://dx.doi.org/10.1093/jac/dks472.